| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2007 | CA2383355C Vitamin b solution with reduced bitterness |
| 09/11/2007 | CA2379314C Tablet for sucking, containing ambroxol |
| 09/11/2007 | CA2372720C Androgen glycosides and androgenic activity thereof |
| 09/11/2007 | CA2349487C Bupropion to treat viral diseases |
| 09/11/2007 | CA2319176C Stable shaped particles of crystalline organic compounds |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2309196C Novel camptothecin derivatives |
| 09/11/2007 | CA2298659C Fast-acting analgesic |
| 09/11/2007 | CA2260889C Granulates of hexahydropyrazine derivatives which can be administered orally |
| 09/11/2007 | CA2259520C Preparation for injection containing a lipid a analog and process for preparing the same |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2254066C Compounds with anti-inflammatory and immunosuppressive activities |
| 09/11/2007 | CA2251226C Use of 2,5-dihydroxybenzenesulphonic derivatives in the manufacture of drugs for normalising the endothelial function and treating sexual dysfunctions, the vascular complications of diabetes and vascular disorders of endothelial origin |
| 09/11/2007 | CA2231975C Substituted amino compounds and their use as substances having an analgesic effect |
| 09/11/2007 | CA2201652C Use of purified sdg as an antioxidant |
| 09/11/2007 | CA2200760C Aqueous compositions containing ciprofloxacine, and related use and process |
| 09/11/2007 | CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 09/11/2007 | CA2188931C Agent for treating cor pulmonale |
| 09/11/2007 | CA2187210C Method for purifying diacetylrhein |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/11/2007 | CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers |
| 09/09/2007 | CA2638622A1 Peripheral and neural inflammatory crosstalk |
| 09/08/2007 | WO2008136788A2 Improved storage stable one component polyurethane system |
| 09/07/2007 | WO2007101270A1 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/07/2007 | WO2007101264A2 Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| 09/07/2007 | WO2007101213A2 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 09/07/2007 | WO2007101204A1 Method of treating glaucoma |
| 09/07/2007 | WO2007101165A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/07/2007 | WO2007101156A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives |
| 09/07/2007 | WO2007101005A2 Compositions and methods for effecting controlled posterior vitreous detachment |
| 09/07/2007 | WO2007101002A2 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 09/07/2007 | WO2007100990A2 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands |
| 09/07/2007 | WO2007100984A2 Beads containing pyridin-sulfinyl benzoimidazole sulfonyl phenoxy acetate derivatives |
| 09/07/2007 | WO2007100910A2 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
| 09/07/2007 | WO2007100902A2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation |
| 09/07/2007 | WO2007100894A2 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | WO2007100883A2 Antimicrobial releasing polymers |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100852A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | WO2007100851A1 Therapeutic compounds |
| 09/07/2007 | WO2007100822A2 Fluvastatin sodium pharmaceutical compositions |
| 09/07/2007 | WO2007100795A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 09/07/2007 | WO2007100776A2 Antimicrobial compositions and methods for locking catheters |
| 09/07/2007 | WO2007100757A2 Transdermal therapeutic system comprising scopolamine |
| 09/07/2007 | WO2007100745A2 Apparatus and formulations for suprachoroidal drug delivery |
| 09/07/2007 | WO2007100728A2 Mannose derivatives for killing tumor cells |
| 09/07/2007 | WO2007100670A1 Spiro condensed piperidnes as modulators of muscarinic receptors |
| 09/07/2007 | WO2007100663A2 Polyamines and their use as antibacterial and sensitizing agents |
| 09/07/2007 | WO2007100646A1 Multi-cyclic compounds and method of use |
| 09/07/2007 | WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | WO2007100562A2 Use of dha and ara in the preparation of a composition for reducing triglyceride levels |
| 09/07/2007 | WO2007100561A2 Use of dha and ara in the preparation of a composition for preventing or treating obesity |
| 09/07/2007 | WO2007100560A2 Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b |
| 09/07/2007 | WO2007100548A1 Use of manzamine compounds in anti-cancer therapeutic regimens |
| 09/07/2007 | WO2007100536A1 DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
| 09/07/2007 | WO2007100525A2 Methods for the treatment of viral diseases |
| 09/07/2007 | WO2007100435A2 Use of dha and ara in the preparation of a composition for the prevention or treatment of anemia |
| 09/07/2007 | WO2007100430A2 Cytisine and acetylcholine analogs and methods of treating mood disorders |
| 09/07/2007 | WO2007100335A1 Methods for the treatment of mood disorders |
| 09/07/2007 | WO2007100305A1 Sensitizing a cell to cancer treatment by modulating the activity of a nucleic acid encoding rps27l protein |
| 09/07/2007 | WO2007100304A1 Methods for cancer therapy and stem cell modulation |
| 09/07/2007 | WO2007100295A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | WO2007100282A1 New salts of an indole derivative and their use in medicine |
| 09/07/2007 | WO2007100151A1 Immunostimulating agent |
| 09/07/2007 | WO2007100103A1 Ameliorating agent for metabolic syndrome |
| 09/07/2007 | WO2007100102A1 Nematicidal composition and nematode eradication method using the same |
| 09/07/2007 | WO2007100091A1 Composition for suppressing the expression of fucosyltransferase |
| 09/07/2007 | WO2007100079A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007100027A1 Optically active thiazolidinedione derivative |
| 09/07/2007 | WO2007099999A1 Novel glycolipid and use thereof |
| 09/07/2007 | WO2007099997A1 Immunostimulating agent and method for production thereof |
| 09/07/2007 | WO2007099981A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | WO2007099966A1 Transdermal absorption preparation |
| 09/07/2007 | WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF |
| 09/07/2007 | WO2007099915A1 Antiviral agent |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099852A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 09/07/2007 | WO2007099830A1 Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition and food composition each using same |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007099711A1 Differentiation inducer |
| 09/07/2007 | WO2007099652A1 Pharmaceutical composition for treatment of blood clotting disorder |
| 09/07/2007 | WO2007099432A2 Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof |
| 09/07/2007 | WO2007099423A1 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| 09/07/2007 | WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions |
| 09/07/2007 | WO2007099335A1 Quinoline derivatives for treating cancer |
| 09/07/2007 | WO2007099326A1 Quinoline derivatives |
| 09/07/2007 | WO2007099317A1 Quinazoline derivatives |
| 09/07/2007 | WO2007099304A1 Steroidal compounds as steroid sulphatase inhibitors |
| 09/07/2007 | WO2007099302A2 Methods of maintaining oral health in animals using morpholine derivatives |
| 09/07/2007 | WO2007099217A1 α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT |
| 09/07/2007 | WO2007099200A1 Selective androgen receptor modulators |
| 09/07/2007 | WO2007099192A1 Method for detecting glycogen by means of fluorescence |
| 09/07/2007 | WO2007099172A1 Melatonin and immunostimulating substance-based compositions |
| 09/07/2007 | WO2007099171A2 Bicyclo-pyrazoles active as kinase inhibitors |
| 09/07/2007 | WO2007099170A1 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome |
| 09/07/2007 | WO2007099166A1 Pyrazolo-pyridine derivatives active as kinase inhibitors |
| 09/07/2007 | WO2007099162A2 Hydroxylated long-chain resveratrol derivatives useful as neurotrophic agents |
| 09/07/2007 | WO2007099117A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them |
| 09/07/2007 | WO2007099070A1 Treatment of prevention of valvular heart disease with flibanserin |